Yukinori Takenaka Selected Research

Neoplasms (Cancer)

3/2024	Validation and comparison of prognostic scoring systems in patients with head and neck squamous cell carcinoma treated with nivolumab.
1/2024	Association of circulating tumor HPV16DNA levels and quantitative PET parameters in patients with HPV-positive head and neck squamous cell carcinoma.
1/2023	Clearance Profile of Circulating Tumor Human Papillomavirus DNA During Radiotherapy Predicts Clinical Outcomes in Human Papillomavirus-Related Oropharyngeal Cancer.
1/2022	Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
10/2021	Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis.
1/2021	Radiation Therapy Alone for Human Papillomavirus-Related Squamous Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.
6/2018	A case of adult congenital laryngeal cleft asymptomatic until hypopharynx cancer treatment.
12/2017	Age-adjusted Charlson Comorbidity Index predicts prognosis of laryngopharyngeal cancer treated with radiation therapy.
10/2017	Metabolic tumor volume of primary tumor predicts survival better than T classification in the larynx preservation approach.
6/2017	Age-adjusted Charlson comorbidity index as a prognostic factor of hypopharyngeal cancer treated with chemoradiation therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukinori Takenaka Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 01/2002
15	Squamous Cell Carcinoma of Head and Neck 03/2024 - 12/2013
7	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2002
7	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016 - 11/2004
5	Carcinoma (Carcinomatosis) 01/2023 - 09/2005
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 07/2015
4	Oropharyngeal Neoplasms 01/2023 - 03/2015
4	Febrile Neutropenia 04/2021 - 10/2013
4	Mucositis 12/2016 - 09/2013
3	Neutropenia 04/2021 - 10/2016
3	Deglutition Disorders (Dysphagia) 06/2018 - 09/2013
3	Hypopharyngeal Neoplasms 10/2017 - 09/2013
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2023 - 12/2013
2	Sarcopenia 10/2021 - 01/2021
2	Nasopharyngeal Carcinoma 10/2016 - 06/2015
2	Thyroid Neoplasms (Thyroid Cancer) 09/2015 - 05/2003
2	Papillary Carcinoma 11/2008 - 05/2003
1	Malnutrition (Nutritional Deficiencies) 10/2023
1	Papillary Thyroid Cancer 01/2023
1	Adenosquamous Carcinoma 01/2023
1	Epistaxis (Nosebleed) 01/2019
1	Sudden Hearing Loss (Sudden Deafness) 12/2018
1	Hearing Loss (Hearing Impairment) 12/2018
1	Sensorineural Hearing Loss 12/2018
1	Pneumonia (Pneumonitis) 06/2018
1	Dyspnea (Shortness of Breath) 06/2018
1	Osteomyelitis 01/2016
1	Vertigo (Positional Vertigo) 09/2015
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 06/2015
1	medullary Thyroid cancer 03/2015
1	Infections 01/2015
1	Pain (Aches) 01/2015
1	Tonsillar Neoplasms 01/2014
1	Diabetes Mellitus 10/2013
1	Necrosis 09/2013
1	Rhabdomyosarcoma 03/2013
1	Peritonsillar Abscess 01/2012
1	Lymphatic Metastasis 12/2008
1	Thyroid Nodule (Nodule, Thyroid) 11/2008
1	Prostatic Neoplasms (Prostate Cancer) 03/2006
1	Breast Neoplasms (Breast Cancer) 05/2004

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 11/2008 - 01/2002
7	Galectin 3 (LGALS3)IBA 11/2008 - 01/2002
6	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2014
6	Docetaxel (Taxotere)FDA Link 04/2021 - 11/2004
6	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 11/2004
3	Immune Checkpoint InhibitorsIBA 10/2023 - 10/2021
3	PlatinumIBA 12/2016 - 10/2013
3	Galectins (Galectin)IBA 01/2004 - 05/2003
2	NivolumabIBA 03/2024 - 01/2022
2	Tumor Biomarkers (Tumor Markers)IBA 01/2024 - 01/2004
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
2	Indicators and Reagents (Reagents)IBA 04/2018 - 03/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 01/2012
2	Alanine (L-Alanine)FDA Link 01/2016 - 05/2004
2	beta-galactosideIBA 05/2004 - 12/2003
2	Carrier Proteins (Binding Protein)IBA 05/2004 - 12/2003
1	B7-H1 AntigenIBA 02/2024
1	Circulating Tumor DNAIBA 01/2024
1	IodineIBA 01/2023
1	ORALIT (ORS)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2021
1	Cetuximab (Erbitux)FDA Link 04/2021
1	Fibrinogen (Factor I)FDA Link 12/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2018
1	Transaminases (Aminotransferases)IBA 01/2016
1	Aspartic Acid (Aspartate)FDA Link 01/2016
1	Cefepime (Maxipime)FDA LinkGeneric 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 10/2015
1	Thyrotropin Alfa FDA LinkGeneric 09/2015
1	squamous cell carcinoma-related antigenIBA 03/2015
1	Codon (Codons)IBA 03/2015
1	taxaneIBA 01/2015
1	Serum AlbuminIBA 01/2015
1	Glutamine (L-Glutamine)FDA Link 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2013
1	EnzymesIBA 11/2008
1	ImmunosorbentsIBA 11/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005
1	LigandsIBA 09/2005
1	WortmanninIBA 09/2005
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 09/2005
1	TNF-Related Apoptosis-Inducing LigandIBA 09/2005
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2005
1	beta CateninIBA 09/2004
1	Serine (L-Serine)FDA Link 05/2004
1	Glutamic Acid (Glutamate)FDA Link 05/2004

Therapy/Procedure

10	Radiotherapy 02/2024 - 11/2004
9	Chemoradiotherapy 06/2018 - 11/2004
8	Therapeutics 01/2023 - 03/2013
4	Drug Therapy (Chemotherapy) 06/2015 - 03/2006
3	Adjuvant Chemotherapy 12/2016 - 06/2015
3	Thyroidectomy 09/2015 - 11/2008
2	Neck Dissection (Radical Neck Dissection) 03/2015 - 12/2008
2	Enteral Nutrition (Feeding, Tube) 01/2015 - 10/2013
1	Cautery 01/2019
1	Ligation 01/2019
1	Laryngectomy 10/2017
1	Tonsillectomy 01/2014